CTS holder plans Rule 144 sale of 25,000 shares

CTS Corporation has a security holder who filed a Rule 144 notice to sell 25,000 shares of common stock through Merrill Lynch, with an aggregate market value of 1324250.

Rhea-AI Filing Summary

CTS Corporation has a security holder who filed a Rule 144 notice to sell 25,000 shares of common stock through Merrill Lynch, with an aggregate market value of 1324250. These shares are part of 29,050,000 common shares outstanding, and the proposed sale date is 02/02/2026 on the NYSE.

The shares to be sold were acquired as stock bonuses from CTS Corporation on multiple dates in 2023 and 2024, with each grant fully paid on its respective grant date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CTS (CTS) Form 144 notice disclose?

The notice discloses a planned sale of 25,000 CTS Corporation common shares under Rule 144. The proposed sale has an aggregate market value of 1,324,250 and will be executed on the NYSE through Merrill Lynch.

How many CTS (CTS) shares are planned to be sold and on which exchange?

A holder plans to sell 25,000 CTS Corporation common shares. The filing states the sale is expected to occur on the NYSE, with Merrill Lynch listed as the broker handling the transaction for this Rule 144 sale.

What is the aggregate market value of the CTS (CTS) shares to be sold?

The filing shows an aggregate market value of 1,324,250 for the 25,000 CTS Corporation common shares. This value is based on the market price at the time of the notice and is reported as part of the Rule 144 disclosure.

How many CTS (CTS) common shares are outstanding according to this filing?

The notice reports 29,050,000 CTS Corporation common shares outstanding. This figure provides context for the 25,000 shares planned for sale under Rule 144, indicating the relative size of the proposed transaction compared with total outstanding shares.

How were the CTS (CTS) shares being sold under Rule 144 originally acquired?

The shares were acquired through multiple stock bonus grants from CTS Corporation in 2023 and 2024. Each grant lists a specific acquisition date, the number of common shares received, and indicates that payment occurred on the same date as each stock bonus.

When is the proposed sale date for the CTS (CTS) shares in this Rule 144 filing?

The filing lists an approximate sale date of 02/02/2026 for the 25,000 CTS Corporation common shares. This date reflects when the holder expects to execute the transaction on the NYSE via Merrill Lynch, subject to market conditions and Rule 144 requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/02/2026 - 05:53 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001529275
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CTS Corporation
SEC File Number	001-04639
Address of Issuer	4925 Indiana Ave Lisle ILLINOIS 60532
Phone	630-577-8800
Name of Person for Whose Account the Securities are To Be Sold	Ashish Agrawal
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 1921 St Johns Ave Highland Park IL 60035	25000	1324250	29050000	02/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/06/2023	Stock Bonus	CTS Corporation			1182	02/06/2023	NA
Common	02/11/2024	Stock Bonus	CTS Corporation			1287	02/11/2024	NA
Common	02/10/2024	Stock Bonus	CTS Corporation			1342	02/10/2024	NA
Common	02/09/2024	Stock Bonus	CTS Corporation			1039	02/09/2024	NA
Common	02/10/2023	Stock Bonus	CTS Corporation			1288	02/10/2023	NA
Common	02/10/2023	Stock Bonus	CTS Corporation			1343	02/10/2023	NA
Common	02/09/2023	Stock Bonus	CTS Corporation			11080	02/09/2023	NA
Common	02/07/2024	Stock Bonus	CTS Corporation			6439	02/07/2024	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/27/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Ashish Agrawal
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)